Results 71 to 80 of about 9,985 (145)

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.

, 2015
Micafungin is an effective antifungal agent useful for the therapy of invasive candidiasis. Candida albicans is the most common cause of invasive candidiasis; however, infections due to non-C.
Jauregizar Nerea, Guillermo Quindós, Quindós Guillermo, Gil-Alonso Sandra, Eraso Elena, Elena Eraso, Nerea Jauregizar, Sandra Gil-Alonso   +7 more
core   +1 more source

Combined inhibitory effects of micafungin on cell growth with other drugs.

, 2013
(A) Micafungin exhibited extremely effective inhibitory activity in combination with AmB. Wild-type cells were spotted onto each plate as indicated and incubated at 27°C for 4 days.(B) FK506 increased micafungin sensitivity of wild-type cells, whereas it
Yuki Yamada (104430), Yan Ma (88810), Xin Zhou (54275), Yue Fang (124565), Wugan gerile (416548), Wurentuya Jaiseng (124568), Takayoshi Kuno (124570)   +6 more
core   +1 more source

resistance to micafungin: A systematic review and meta‐analysis

, 2019
International audienceSummary Candida resistance to antifungals impaired invasive candidiasis outcome. In a context of echinocandin resistance development, we aimed to evaluate the association between phenotypic resistance to micafungin and fks mutations
Stephane Picot, Leboucher, Gilles, Picot, Stéphane, Anne‐Lise Bienvenu, Gilles Leboucher, Bienvenu, Anne‐lise   +5 more
core   +1 more source

Evaluation of Micafungin Use in Children

Micafungin is recommended especially in patients with liver and kidney failure and in the presence of other side effects due to antifungals apart from its known priority indications such as invasive candidiasis.
Sevinir, B, Düzcan Kilimci, D, Timur, D, Köksal, N, Yesil, E, Özkan, H, Özer, A, Günes, AM, Bülbül, B, Hacimustafaoglu, M, Çakir, SC, Çelebi, S, Turan, C, Ener, B, Sezgin Evim, M   +14 more
core  

<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]

JAC Antimicrob Resist
Klamer KS, Bhargava A, Johnson L, Sharma M, Saravolatz LD.   +4 more
europepmc   +1 more source

Repurposing caspofungin as a small-molecule inhibitor of Clostridium perfringens α-toxin for treatment of gas gangrene. [PDF]

Commun Med (Lond)
Takehara M, Homma Y, Ishihara T, Sakaguchi Y, Kasai Y, Matsumoto K, Nakashima K, Yamaji T, Tanaka Y, Imagawa H, Nagahama M.   +10 more
europepmc   +1 more source

Micafungin microevolution in <i>Candida auris</i> reveals resistance development without <i>in vivo</i> fitness compromise. [PDF]

Virulence
Bohner F, Szilovics Z, Veres É, Papp C, Nosanchuk JD, Gácser A.   +5 more
europepmc   +1 more source

Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of <i>Aspergillus fumigatus</i> to echinocandins with the EUCAST E.Def 9.4. [PDF]

J Clin Microbiol
Meletiadis J, Siopi M, Meinike Jørgensen K, Escribano P, Guinea J, Arendrup MC.   +5 more
europepmc   +1 more source

Evaluation of Sensititre YeastOne for antifungal susceptibility testing of <i>Candida (Candidozyma) auris</i>: misclassification of <i>FKS1</i> mutants and overestimation of caspofungin resistance in a global collection of isolates. [PDF]

J Clin Microbiol
Siopi M, Leventaki S, Pachoulis I, Rentoumi A, Argyris N, Spruijtenburg B, Meijer EFJ, Meis JF, Pournaras S, Tsakris A, Vrioni G, Meletiadis J.   +11 more
europepmc   +1 more source

<i>Scopulariopsis</i> fungal endophthalmitis after cataract surgery requiring enucleation. [PDF]

Med Mycol Case Rep
Qin S, Shah RE, Rubinstein TJ, Parekh P, Godwin KS.   +4 more
europepmc   +1 more source